It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
The treatment, developed by SaNOtize Research and Development Corp. based in Vancouver, Canada, proved 99.9% effective in killing the coronavirus in independent lab tests at Utah State University’s Antiviral Research Institute. Additional studies in rodents with COVID-19 infection showed over 95% reduction within the first day after infection. It is currently undergoing Phase II clinical trials throughout Canada approved by Health Canada, and in other countries.
Biotech company SaNOtize Research & Development Corp., (SaNOtize), Ashford and St Peter’s Hospitals NHS Foundation Trust in Surrey, UK, and Berkshire and Surrey Pathology Services, UK,
today announced results of clinical trials indicating that SaNOtize’s Nitric Oxide Nasal Spray (NONS) represents a safe and effective antiviral treatment that could prevent the transmission of COVID-19, shorten its course, and reduce the severity of symptoms and damage in those already infected.
“NONS destroys the virus, blocks entry into and halts viral replication within the nasal cavity, which rapidly reduces viral load. This is significant because viral load has been linked to infectivity and poor outcomes”
Key findings of the clinical trials include:
Patients with a self-administered nasal spray application found to have reduced SARS-CoV-2 log viral load by more than 95%
in infected participants within 24 hours of treatment, and by more than 99% in 72 hours
Trial concluded that treatment accelerated clearance of SARS-CoV-2 by a factor of 16-fold versus a placebo
Randomised, double-blind, placebo-controlled trial evaluated 79 confirmed cases of COVID-19, the majority heavily-infected with the UK variant
No adverse events were recorded in the group
Submission for Emergency Use in the UK and Canada for the treatment and prevention of COVID-19 is planned immediately
originally posted by: Liquesence
Received my first dose of the Pfizer vaccine today, about four hours ago. Second dose is scheduled for a month.
An Amish community in Pennsylvania may have become the first group in the US to achieve herd immunity, a local health official claims.
The administrator of a medical center in the heart of Lancaster County’s New Holland Borough, which is known for its Amish and Mennonite communities, estimates that as many as 90 percent of the religious families have had at least one family member infected with the virus.
“So, you would think if COVID was as contagious as they say, it would go through like a tsunami; and it did,” said Allen Hoover, an administrator of the Parochial Medical Center, which caters to the religious community and has 33,000 patients.
originally posted by: Liquesence my butthole hasn't turned inside out nor has my pecker fallen off.